Calidi Biotherapeutics, Inc. (CLDI)
NYSE: CLDI · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2021
Who owns Calidi Biotherapeutics, Inc.
As filed with the SECHolders of 5% or more
1
Kessler Judd S holds 5% of Common Stock, as its SCHEDULE 13D filed May 1, 2024 says.
Directors and officers
n/a
The record holds no Form 3, 4 or 5 for this company yet.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Kessler Judd S
SCHEDULE 13D · filed May 1, 2024 · Common Stock
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common stock, par value $0.0001 per share · reported falling below 5%, from 9.99% in May 15, 2026
Gavrilov Ognian Anguelov
SCHEDULE 13D · filed Mar 31, 2026 · Common Stock, $0.0001 par value · reported falling below 5%, from 9.8% in Mar 9, 2026
Lincoln Alternative Strategies LLC
SCHEDULE 13G/A · filed Feb 10, 2026 · Common stock, par value $0.0001 per share · reported falling below 5%, from 14.5% in Aug 27, 2025
What CLDI reports owning in othersstakes of 5% or more, and other ties
4 subsidiaries in 3 countries, from the list filed with the 10-K filed Mar 27, 2026.
Insider tradesForm 4
The record holds no insider filings for this company yet.